Publicacions en què col·labora amb María Josefa Montero Gómez (37)

2025

  1. Phytochemical analysis of Passiflora quadrangularis L. and its potential role in hypertension and cardiac remodeling

    Journal of Pharmacy and Pharmacognosy Research, Vol. 13, Núm. 6, pp. 1649-1677

2021

  1. The antihypertensive and antihypertrophic effect of lycopene is not affected by and is independent of age

    Journal of Functional Foods, Vol. 85

2020

  1. Implication of Opioid Receptors in the Antihypertensive Effect of a Bovine Casein Hydrolysate and αs1-Casein-Derived Peptides

    Journal of Agricultural and Food Chemistry, Vol. 68, Núm. 7, pp. 1877-1883

  2. Lycopene-supplemented diet ameliorates metabolic syndrome induced by fructose in rats

    Journal of Functional Foods, Vol. 73

2019

  1. Vagal afferents contribute to sympathoexcitation-driven metabolic dysfunctions

    Journal of Endocrinology, Vol. 240, Núm. 3, pp. 483-496

  2. Vav proteins maintain epithelial traits in breast cancer cells using miR-200c-dependent and independent mechanisms

    Oncogene, Vol. 38, Núm. 2, pp. 209-227

2018

  1. Lycopene-supplemented diet ameliorates cardiovascular remodeling and oxidative stress in rats with hypertension induced by Angiotensin II

    Journal of Functional Foods, Vol. 47, pp. 279-287

2017

  1. Effects of milk casein hydrolyzate supplemented with phytosterols on hypertension and lipid profile in hypercholesterolemic hypertensive rats

    Journal of Functional Foods, Vol. 28, pp. 168-176

  2. Plk1 regulates contraction of postmitotic smooth muscle cells and is required for vascular homeostasis

    Nature Medicine, Vol. 23, Núm. 8, pp. 964-974

  3. Vasorelaxan Effect and Potent Antioxidant Activity of Natural Flavones Isolated from Lourteigia stoechadifolia and Ageratina stevioides, Two Venezuelan Plants

    European Journal of Medicinal Plants, Vol. 18, Núm. 2, pp. 1-10

2016

  1. Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition

    Journal of Pharmacy and Pharmacology, Vol. 68, Núm. 11, pp. 1422-1429

2015

  1. Immunosuppression-Independent Role of Regulatory T Cells against Hypertension-Driven Renal Dysfunctions

    Molecular and Cellular Biology, Vol. 35, Núm. 20, pp. 3528-3546

2014

  1. Genetic dissection of the Vav2-Rac1 signaling axis in vascular smooth muscle cells

    Molecular and Cellular Biology, Vol. 34, Núm. 24, pp. 4404-4419

  2. Zofenopril evita las alteraciones cardiovasculares en ratones con infusión de Ang II

    Revista en Actualidad en Farmacología y Terapéutica

2013

  1. Licopeno previene la hipertensión y la hipertrofia cardiovascular producida por angiotensina

    Actualidad en farmacología y terapéutica, Vol. 11, Núm. 4, pp. 279-281

  2. Pravastatin improves endothelial function in arteries used in coronary bypass grafting

    Journal of Cardiovascular Pharmacology, Vol. 61, Núm. 6, pp. 513-519

2012

  1. Acute effect of whey peptides upon blood pressure of hypertensive rats, and relationship with their angiotensin-converting enzyme inhibitory activity

    Molecular Nutrition and Food Research, Vol. 56, Núm. 2, pp. 316-324

2011

  1. Astaxanthin-enriched-diet reduces blood pressure and improves cardiovascular parameters in spontaneously hypertensive rats

    Pharmacological Research, Vol. 63, Núm. 1, pp. 44-50

  2. Long-term intake of a milk casein hydrolysate attenuates the development of hypertension and involves cardiovascular benefits

    Pharmacological Research, Vol. 63, Núm. 5, pp. 398-404

  3. Transcriptional factor Aryl hydrocarbon receptor (Ahr) controls cardiovascular and respiratory functions by regulating the expression of the Vav3 proto-oncogene

    Journal of Biological Chemistry, Vol. 286, Núm. 4, pp. 2896-2909